ERBB2 and breast carcinoma: For example, inferences from an RCT comparing therapies that target human epidermal growth factor receptor 2 (HER2) signaling in breast cancer may be transported if a patient seen in the clinic has breast cancer driven by HER2 signaling, despite the fact that the clinic population is otherwise completely separate in space and time from the sample enrolled in the RCT [2,82].